Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Enhancing Capacity for Strategic and Applied Research Activities in Support of Control and Elimination of Malaria and Neglected Tropical Diseases
The purpose of this cooperative agreement is to advance strategic and applied research in support of malaria and neglected tropical disease (NTD) control and elimination, particularly in sub-Saharan Africa, Asia, and Hispaniola.
Through this funding announcement, the Division of Parasitic Diseases
and Malaria (DPDM) seeks to fund critical implementation research projects and evaluation activities in two critical areas:
Component A:
Malaria and Component B:
NTDs.
The Centers for Disease Control and Prevention (CDC) is a partner of the Roll Back Malaria (RBM) initiative and a World Health Organization (WHO) Collaborating Center, and seeks to support and coordinate global malaria program scale-up, surveillance, and evaluation efforts in malaria endemic countries.
In addition, along with the US Agency for International Development (USAID), CDC’s Malaria Branch co-implements the US President’s Malaria Initiative.
While there has been tremendous recent progress toward malaria elimination, there is a critical need for ongoing research to improve malaria control interventions.
Supported malaria research activities will be based on the WHO Global Technical Strategy for Malaria 2016—2030, will be designed to yield high impact public health findings, and to improve strategies aimed at controlling and ultimately eliminating malaria.
CDC also provides technical assistance in support of, and conducts operational research related to, efforts to eliminate onchocerciasis where possible, eliminate blinding trachoma and lymphatic filariasis as public health problems, and control schistosomiasis and soil-transmitted helminths.
CDC supports global NTD control and elimination efforts in collaboration with USAID and WHO.
Supported NTD research strategies will be focused on identifying strategies to strengthen NTD program scale up, and surveillance and evaluation efforts in NTD endemic countries in order to meet elimination and control goals
Through this funding announcement, the Division of Parasitic Diseases
and Malaria (DPDM) seeks to fund critical implementation research projects and evaluation activities in two critical areas:
Component A:
Malaria and Component B:
NTDs.
The Centers for Disease Control and Prevention (CDC) is a partner of the Roll Back Malaria (RBM) initiative and a World Health Organization (WHO) Collaborating Center, and seeks to support and coordinate global malaria program scale-up, surveillance, and evaluation efforts in malaria endemic countries.
In addition, along with the US Agency for International Development (USAID), CDC’s Malaria Branch co-implements the US President’s Malaria Initiative.
While there has been tremendous recent progress toward malaria elimination, there is a critical need for ongoing research to improve malaria control interventions.
Supported malaria research activities will be based on the WHO Global Technical Strategy for Malaria 2016—2030, will be designed to yield high impact public health findings, and to improve strategies aimed at controlling and ultimately eliminating malaria.
CDC also provides technical assistance in support of, and conducts operational research related to, efforts to eliminate onchocerciasis where possible, eliminate blinding trachoma and lymphatic filariasis as public health problems, and control schistosomiasis and soil-transmitted helminths.
CDC supports global NTD control and elimination efforts in collaboration with USAID and WHO.
Supported NTD research strategies will be focused on identifying strategies to strengthen NTD program scale up, and surveillance and evaluation efforts in NTD endemic countries in order to meet elimination and control goals
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $13,300,000
Office: Centers for Disease Control and Prevention - ERA
Estimated Funding: $13,300,000
Who's Eligible
Obtain Full Opportunity Text:
http://www.grants.gov/
Additional Information of Eligibility:
Applicants under Component A: Malaria and Component B: NTDs must demonstrate an ability to conduct epidemiologic and entomologic studies where they propose to work in sub-Saharan Africa, Asia or Hispaniola.
This should include a proven record of accomplishment in organizing and managing large groups of diverse research institutions, international public health groups, and Ministries of Health for the purpose of identifying the malaria or NTD research agendas and implementing research studies across multiple sites and epidemiologic transmission zones.
Applicants must demonstrate previous malaria or NTD research or public health activities in sub-Saharan Africa, Asia, or Haiti.
Applicants should document eligibility through manuscripts showing previous work in these regions or through reference letters from public health officials.
Full Opportunity Web Address:
http://www.grants.gov/
Contact:
Agency Email Description:
Grants Policy
Agency Email:
Date Posted:
2018-01-11
Application Due Date:
Archive Date:
2018-04-11
Social Entrepreneurship
Spotlight
Building a Million Dollar Company Where Everyone Counts
Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.
Learn How to Identify and Avoid Grant Scams
